STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Income Statement
REVENUES		$ 377		$ 642
GROSS LOSS		377		642
Research and Development Expense	37,200		37,200
Selling, general and administrative	211,428	191,266	431,820	386,268
TOTAL OPERATING EXPENSES	248,628	191,266	469,020	386,268
LOSS FROM OPERATIONS	(248,628)	(190,889)	(469,020)	(385,626)
OTHER (INCOME) EXPENSES
Interest Expense	316,560	124,608	527,796	224,994
Derivative expense	130,028	(41,699)	124,090	81,241
Interest expense - related parties	3,074	2,925	6,150	5,850
TOTAL OTHER EXPENSES	449,662	169,232	658,038	312,085
Net Income (Loss)	(698,290)	(360,121)	(1,127,058)	(697,711)
Common stock dividends to be issued for Series B Preferred Stock	117,002	117,542	231,960	232,500
NET LOSS APPLICABLE TO COMMON STOCK HOLDERS	$ (815,292)	$ (477,663)	$ (1,359,018)	$ (930,211)
BASIC AND DILUTED - LOSS PER SHARE	$ (0.03)	$ (0.68)	$ (0.04)	$ (1.61)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic and Diluted	24,583,687	705,930	36,558,358	577,082